Gentiva Health Services, Inc. (NASDAQ:GTIV)
The Company provides comprehensive home health and related services throughout the United States.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Health services is bullish no?
Recs
if itsmells like a value trap it probably is. Never-the-less, it's cheap
Recs
Their high debt load combined with increasing uncertainty with medicare payments is going to either cause this company to either go out of business or shrink since they can't possibly sustain the situation with deteriorating fundamentals.
Recs
Recs
Ridiculous Price/Sales
Recs
Gentiva is moving up fast every day. A 10+ dollar stock (minimum) in the $4 range? Yes please.
Recs
Exploded once it hit 3.90, and meeting resistance at 5.30 today. I think there will be a move to 5.30 tomorrow and if it gets there it could take off big again.
Recs
It is now undervalued. Every bad thing that could ever happen has happened. It is not about cash flow. People in Greece can fart all they want and it can't drop much more. Upside is big percentage-wise.
Recs
8/31/2011 7.86 showed on the cold list, good model, beaten way down.
Recs
This company got bludgeoned way too severely. It probably won't perform as well for me as it did for the people who shorted it a week and a half ago, but it looks like a small feeding frenzy developing here.
Recs
Recs
2002 prices = falling knife. I know next to nothing about this company except there's lots of highly-rated CAPS buying interest in it the last few days, and it's likely to at least bounce a little from here...
Recs
Wow this looks cheap. The market has overreacted and it is time to pick this one up while it is on sale. It's trading below half of book value and the brand name alone is enough to warrant a buyout. I am in.
P-Worm
Recs
Wonder if I can catch this falling knife?
Recs
Bouncing back after a recent decline.
Recs
Gentiva Health Services is being added to the limit buy list to join Amedisys, but to be clear Amedisys appears marginally a better value of the two, thus the limit buy order on Gentiva further away from its current price as opposed to Amedisys. Gentiva dipped below its book value today and has lost almost 1/3rd of its value on news that the SEC is investigating the way home health company's bill and collect revenues. I think this will result in yet another hand slap for the industry and will have little to no material impact on the sector. Fear and panic have swept in to drag down GTIV but trading at roughly 7.5 times forward profits there is plenty to be cheery about. Long-term growth rates here are 7% so the PEG is right in line if not below the industry average and although they are 55M in the debt hole, they are churning nearly 100M in gross profits each year, so this doesn't worry me one bit. I'm placing a limit buy order at $14.94 and attempting to nab a falling knife at roughly 5.5 times forward numbers and only 0.75 times book value if it hits.
UltraLong
Recs
Technical--Chart
Recs
A huge, federal Fair Labor Standards Act (FLSA), class action suit, filed by employees, may drain Gentiva's cash and produce negative confidence in the minds of potential patients, clients, and investors. Employees in NY and NC are included in the suit. When will employees from other states file?
Recs
running a new screen.
Recs
I think this stock is about 60% undervalued. Whatever health care legislation is passed, I don't believe it will hurt the earnings for this home health care company.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 36 : 1 2 Next »